147 related articles for article (PubMed ID: 8429543)
1. Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model.
Gilleland HE; Gilleland LB; Fowler MR
J Med Microbiol; 1993 Feb; 38(2):79-86. PubMed ID: 8429543
[TBL] [Abstract][Full Text] [Related]
2. Preservation of pulmonary function by an outer membrane protein F vaccine. A study in rats with chronic pulmonary infection caused by Pseudomonas aeruginosa.
Fox CW; Campbell GD; Anderson WM; Zavecz JH; Gilleland LB; Gilleland HE
Chest; 1994 May; 105(5):1545-50. PubMed ID: 8181349
[TBL] [Abstract][Full Text] [Related]
3. Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model.
Gilleland HE; Gilleland LB; Matthews-Greer JM
Infect Immun; 1988 May; 56(5):1017-22. PubMed ID: 2833440
[TBL] [Abstract][Full Text] [Related]
4. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
Homma JY; Tanimoto H
Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783
[No Abstract] [Full Text] [Related]
5. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
[TBL] [Abstract][Full Text] [Related]
6. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection.
Chen TY; Shang HF; Chen TL; Lin CP; Hui CF; Hwang J
Appl Microbiol Biotechnol; 1999 Oct; 52(4):524-33. PubMed ID: 10570800
[TBL] [Abstract][Full Text] [Related]
7. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection.
Staczek J; Gilleland HE; Gilleland LB; Harty RN; García-Sastre A; Engelhardt OG; Palese P
Infect Immun; 1998 Aug; 66(8):3990-4. PubMed ID: 9673294
[TBL] [Abstract][Full Text] [Related]
8. Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice.
Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
J Med Microbiol; 1998 Apr; 47(4):295-301. PubMed ID: 9568994
[TBL] [Abstract][Full Text] [Related]
9. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
Yamamoto M; Kubota Y; Matsuura M; Homma JY
Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
[No Abstract] [Full Text] [Related]
10. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
Yamamoto M; Kubota Y; Matsuura M; Homma JY
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
[No Abstract] [Full Text] [Related]
11. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
[TBL] [Abstract][Full Text] [Related]
12. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
Homma JY; Tanimoto H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353
[No Abstract] [Full Text] [Related]
13. Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.
Price BM; Galloway DR; Baker NR; Gilleland LB; Staczek J; Gilleland HE
Infect Immun; 2001 May; 69(5):3510-5. PubMed ID: 11292786
[TBL] [Abstract][Full Text] [Related]
14. [Study of protective properties of recombinant atoxic form of exotoxin A and recombinant outer membrane protein F of Pseudomonas aeruginosa].
Mikhaĭlova NA; Vertiev IuV; Kaloshin AA; Isakov MA
Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):39-44. PubMed ID: 20464999
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J
Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa.
Price BM; Barten Legutki J; Galloway DR; von Specht BU; Gilleland LB; Gilleland HE; Staczek J
FEMS Immunol Med Microbiol; 2002 Jun; 33(2):89-99. PubMed ID: 12052563
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccines against chronic lung infections by Pseudomonas aeruginosa.
Staczek J; Gilleland LB; van der Heyde HC; Gilleland HE
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):147-53. PubMed ID: 12832118
[TBL] [Abstract][Full Text] [Related]
18. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.
Baltch AL; Franke M; Smith RP; Asperilla M; Griffin P; Michelsen P; Lutz F
Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810
[TBL] [Abstract][Full Text] [Related]
19. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
Matthews-Greer JM; Gilleland HE
J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
[TBL] [Abstract][Full Text] [Related]
20. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
Pier GB
Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
